Literature DB >> 24398670

Inhibition of the nuclear transporter, Kpnβ1, results in prolonged mitotic arrest and activation of the intrinsic apoptotic pathway in cervical cancer cells.

Liselotte Angus1, Pauline J van der Watt, Virna D Leaner.   

Abstract

The karyopherin β proteins are involved in nuclear-cytoplasmic trafficking and are crucial for protein and RNA subcellular localization. We previously showed that Kpnβ1, a nuclear importin protein, is overexpressed in cervical cancer and is critical for cervical cancer cell survival and proliferation, whereas non-cancer cells are less dependent on its expression. This study aimed to identify the mechanisms by which inhibition of Kpnβ1 results in cervical cancer cell death. We show that the inhibition of Kpnβ1 results in the induction of apoptosis and a prolonged mitotic arrest, accompanied by distinct mitotic defects in cervical cancer cells but not non-cancer cells. In cervical cancer cells, Kpnβ1 downregulation results in sustained degradation of the antiapoptotic protein, Mcl-1, and elevated Noxa expression, as well as mitochondrial membrane permeabilization resulting in the release of cytochrome C and activation of associated caspases. Although p53 becomes stabilized in Kpnβ1 knockdown cervical cancer cells, apoptosis occurs in a p53-independent manner. These results demonstrate that blocking Kpnβ1 has potential as an anticancer therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24398670     DOI: 10.1093/carcin/bgt491

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  16 in total

1.  Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma.

Authors:  Song He; Xiaobing Miao; Yaxun Wu; Xinghua Zhu; Xianjing Miao; Haibing Yin; Yunhua He; Chunsun Li; Yushan Liu; Xiaoyun Lu; Yali Chen; Yuchan Wang; Xiaohong Xu
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-23       Impact factor: 4.553

2.  Suppression of the nuclear transporter-KPNβ1 expression inhibits tumor proliferation in hepatocellular carcinoma.

Authors:  Linlin Yang; Baoying Hu; Yixin Zhang; Songlin Qiang; Jin Cai; Wei Huang; Chen Gong; Tingting Zhang; ShuSen Zhang; Pan Xu; Xuming Wu; Jibin Liu
Journal:  Med Oncol       Date:  2015-03-21       Impact factor: 3.064

3.  Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer.

Authors:  Demetra P Kelenis; Kathia E Rodarte; Rahul K Kollipara; Karine Pozo; Shreoshi Pal Choudhuri; Kyle B Spainhower; Sarah J Wait; Victor Stastny; Trudy G Oliver; Jane E Johnson
Journal:  Cancer Res       Date:  2022-09-02       Impact factor: 13.312

Review 4.  The nuclear export protein XPO1 - from biology to targeted therapy.

Authors:  Asfar S Azmi; Mohammed H Uddin; Ramzi M Mohammad
Journal:  Nat Rev Clin Oncol       Date:  2020-11-10       Impact factor: 66.675

5.  Decreased KPNB1 Expression is Induced by PLK1 Inhibition and Leads to Apoptosis in Lung Adenocarcinoma.

Authors:  Noboru Sekimoto; Yutaka Suzuki; Sumio Sugano
Journal:  J Cancer       Date:  2017-11-06       Impact factor: 4.207

6.  Suppression of Kpnβ1 expression inhibits human breast cancer cell proliferation by abrogating nuclear transport of Her2.

Authors:  Chenyi Sheng; Jian Qiu; Zhixian He; Hua Wang; Qingqing Wang; Zengya Guo; Lianxin Zhu; Qichao Ni
Journal:  Oncol Rep       Date:  2017-12-12       Impact factor: 3.906

7.  KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells.

Authors:  Tamara Stelma; Virna D Leaner
Journal:  Oncotarget       Date:  2017-05-16

8.  KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells.

Authors:  Zhi-Chuan Zhu; Ji-Wei Liu; Kui Li; Jing Zheng; Zhi-Qi Xiong
Journal:  Oncogene       Date:  2018-03-09       Impact factor: 9.867

9.  Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy.

Authors:  Chie Ishikawa; Masachika Senba; Naoki Mori
Journal:  Invest New Drugs       Date:  2020-09-21       Impact factor: 3.850

10.  Ten hub genes associated with progression and prognosis of pancreatic carcinoma identified by co-expression analysis.

Authors:  Zhou Zhou; Yian Cheng; Yinan Jiang; Shi Liu; Meng Zhang; Jing Liu; Qiu Zhao
Journal:  Int J Biol Sci       Date:  2018-01-12       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.